The effect of an agglutogen on virus infection: biotinylated filamentous phages and avidin as a model

Michihiro Nakamura1, Kouhei Tsumoto, Kazunori Ishimura

  • 1Department of Anatomy and Cell Biology, School of Medicine, Tokushima University, 3-18-15 Kuramoto, Tokushima 770-8503, Japan. michy@basic.med.tokushima-u.ac.jp

FEBS Letters
|June 5, 2002
PubMed

Insights

Avidin and antibodies act as agglutogens, inhibiting M13 phage infections by forming aggregates. This suggests agglutogens could be novel antiviral drugs.

Area of Science:

  • Virology
  • Immunology
  • Biochemistry

Background:

  • Biotinylated M13 phages (BIO-phages) were used to study the impact of agglutogens on viral infection.
  • Avidin and antibodies were investigated for their potential to inhibit phage infection through aggregation.

Purpose of the Study:

  • To investigate the mechanism by which avidin and antibodies inhibit BIO-phage infection.
  • To determine if agglutogens can serve as novel antiviral agents.

Main Methods:

  • Microscopic observation of BIO-phages mixed with avidin-fluorescein conjugates to detect aggregate formation.
  • Assessing the inhibitory effects of avidin and anti-M13 phage antibody on BIO-phage infection of Escherichia coli at varying concentrations and time points.

Main Results:

  • Avidin and anti-M13 phage antibody both induced significant aggregation of BIO-phages, inhibiting infection.
  • Avidin inhibition was observed at >= 2 microg/ml and was time-dependent, effective within 10 minutes.
  • Antibody inhibition occurred at >= 0.1 microg/ml, was dose-dependent, and effective up to 45 minutes.

Conclusions:

  • Avidin and antibodies function as agglutogens, inhibiting phage infection via aggregate formation.
  • Avidin's inhibition mechanism is linked to its tetramerization.
  • Agglutogens represent a promising class of potential antiviral therapeutics.

Related Concept Videos